KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis

Zusammenfassung

KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS Kidney International(2024)105(Suppl 1S), S1–S69S1 KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis S3Tables,figures, and Supplementary Materials S6KDIGO Executive Committee S7Reference keys S8CKD nomenclature S9Conversion factors S10Abbreviations and acronyms S11Notice S12Foreword S13Work Group membership S14Abstract S15Summary of recommendation statements and practice points S23Lupus nep

Kerninformationen

GO). The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the ...

ble 3. Grading the certainty of the evidence S55 Table 4. GRADE system for grading certainty of evidence S56 Table 5. KDIGO nomenclature and description for grading recommendations S56 Table 6. Determinants of the strength of recommendation FIGURES S15 S24 S16 S17 S30 S31 S18 S39 S19 S19 S20 ...

oach for initial therapy of active Class III/IV lupus nephritis Cyclophosphamide dosing regimens, combined with glucocorticoids, in initial treatment for active Class III/IV lupus nephritis Figure 7. Examples of glucocorticoid regimens for lupus nephritis Figure 8. Recommended options of maintenance...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen